TrialLeukemia research2016
Long-term results of a phase II trial of lenalidomide plus prednisone therapy for patients with myelofibrosis.
Dai Chihara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this paperpooled itcites it